Journal of the Japan Society for Healthcare Administration
Online ISSN : 2185-422X
Print ISSN : 1882-594X
ISSN-L : 1882-594X
Volume 47, Issue 1
Displaying 1-6 of 6 articles from this issue
PERSPECTIVE
ORIGINAL ARTICLE
  • —— Cost-effectiveness of pharmacotherapies in view of lifetime health care costs ——
    Hiromi YASUDA, Shunya IKEDA
    2010 Volume 47 Issue 1 Pages 9-16
    Published: 2010
    Released on J-STAGE: October 01, 2010
    JOURNAL FREE ACCESS
    We used a Markov model to assess the cost-effectiveness of the smoking cessation therapies currently performed in Japan. We estimated lifetime health care costs by including diseases unassociated with smoking as well as diseases associated with smoking, and the cost per life year saved (LYS) was calculated with discounting at an annual rate of 3%. The incremental cost-effectiveness ratio for a 40-year-old male in comparison with no therapy was 5.335 million yen/LYS in an over-the-counter patch group, 5.678 million yen/LYS in an over-the-counter gum group, 5.358 million yen/LYS in a prescribed patch group, and 5.428 million yen/LYS in a prescribed oral medication group. For a 40-year-old female, the reduction was 560 thousand yen/LYS in an over-the-counter patch group, 336 thousand yen/LYS in an over-the-counter gum group, 539 thousand yen/LYS in a prescribed patch group, 491 thousand yen/LYS in a prescribed oral medication group. The differences in cost and effectiveness among them were small, and the cost-effectiveness of all of the smoking cessation therapies was considered to be favorable. Because the data in Japan related to smoking cessation success rates, health care costs, etc., were scarce, it would be desirable to wait until data are accumulated and further validate cost-effectiveness in the future.
    Download PDF (355K)
RESEARCH NOTE
  • —— Comparison between the QOLs of inpatients and their community-dwelling counterparts ——
    Satomi TAKAHASHI, Nobuo KOINUMA, Michiya ITO, Sayuri KANEKO
    2010 Volume 47 Issue 1 Pages 17-25
    Published: 2010
    Released on J-STAGE: October 01, 2010
    JOURNAL FREE ACCESS
    Currently, schizophrenic patients are encouraged to receive home based medical care. The belief is that understanding of the QOL of these patients who were moved from hospitals to their communities while receiving care will serve as references to evaluate the policies currently being promoted and to implement home based medical care within the framework of psychiatry.
    In the current study, EQ-5D, a comprehensive QOL scale, and QOLI, a psychiatric disease-specific scale, were employed. The differences between the QOLs of the inpatient group and the regional patients were clearly delineated and the significance of the regional medical care programs was discussed. The survey was conducted between October 2005 and June 2006, during which 107 patients who satisfied the criteria (68 inpatients and 39 outpatients) were interviewed.
    The results of the survey indicated that among the inpatients, assurance of privacy was considered to be one of the major factors related to an improved QOL. Among the regional patients, residents of group homes, in comparison with other subgroups, showed a greater degree of being satisfied with their life, indicating that group homes are perhaps the best environment for the patients to settle down after discharge from hospitals.
    Download PDF (376K)
CORRECTION
SPECIAL LECTURE
feedback
Top